HVIVO
hVIVO, a specialty biopharma company with clinical testing capabilities, is pioneering a human-based analytical platform to accelerate drug discovery and development in respiratory and infectious diseases. hVIVO changed its name from Retroscreen Virology in April 2015. The business is a plc quoted on the AIM London Stock Exchange (ticker ‘HVO’).
HVIVO
Industry:
Biotechnology Health Care Medical
Founded:
1988-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.hvivo.com
Total Employee:
501+
Status:
Active
Contact:
+44 20 7756 1300
Email Addresses:
[email protected]
Total Funding:
2.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-03-04 | Activiomics | Activiomics acquired by hVIVO | 4 M GBP |
Investors List
Aquarius Equity Partners
Aquarius Equity Partners investment in Series B - hVIVO
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2016-04-28 | Imutex | hVIVO investment in Seed Round - Imutex | 14 M GBP |
| 2015-11-02 | PrEP Biopharm | hVIVO investment in Series A - PrEP Biopharm | 21 M GBP |
Official Site Inspections
http://www.hvivo.com Semrush global rank: 3.5 M Semrush visits lastest month: 4.26 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "hVIVO"
About Us | World Leaders in Clinical Trials - hVIVO
Group companies overview. In January 2020, hVIVO merged with Open Orphan plc, a rapidly growing niche CRO pharmaceutical services company. On 26 October 2022, Open Orphan plc …See details»
Executive Leadership Team | hVIVO
HVIVO is led by a dynamic group of experts in their respective fields who are driving excellence throughout the organisation. Leadership Team. Board of Directors. Chairman. Cathal Friel. …See details»
hVIVO - Crunchbase Company Profile & Funding
FluCamp is hVIVO's volunteer recruitment brand, recruiting healthy volunteers for human challenge trials to advance medical research in infectious and respiratory diseases. hLAB: hLAB is hVIVO's virology and immunology laboratory offering …See details»
hVIVO Company Profile | Management and Employees List
HVIVO Profile and History. Founded in 1989 and headquartered in London, UK, hVIVO is a specialty biopharma company with clinical testing capabilities, that is pioneering a human …See details»
hVIVO - LinkedIn
HVIVO plc (ticker: HVO) is a fast growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using …See details»
hVIVO - AnnualReports.com
HVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease …See details»
hVIVO Overview | SignalHire Company Profile
HVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation ... Organization Website: hvivo.com : hVIVO industries Biotech: …See details»
hVIVO Company Profile 2024: Valuation, Investors, Acquisition
When was hVIVO founded? hVIVO was founded in 1989. Where is hVIVO headquartered? hVIVO is headquartered in London, United Kingdom. What is the size of hVIVO? hVIVO has 196 total …See details»
hVIVO - Products, Competitors, Financials, Employees, …
HVIVO is a specialist contract research organization and is involved in conducting human challenge clinical trials for testing infectious and respiratory disease vaccines and …See details»
hVIVO Company Profile - Office Locations, Competitors, Revenue …
Oct 1, 2024 hVIVO has 5 employees across 2 locations and £11.03 m in annual revenue in FY 2018. See insights on hVIVO including office locations, competitors, revenue, financials, …See details»
Company hVIVO plc OTC Markets - MarketScreener.com
Nov 30, 2018 hVIVO plc is a United Kingdom-based specialist contract research organization (CRO). The Company is engaged in testing infectious and respiratory disease vaccines and …See details»
Company Information - hvivo.com
A record year for the hVIVO Group Annual Report and Accounts / 31 December 2023 STRATEGIC REPORT CORPORATE GOVERNANCE FINANCIAL STATEMENTS 01 267787 …See details»
hVIVO PLC, HVO:LSE profile - FT.com - Financial Times
Dec 13, 2024 hVIVO plc is a United Kingdom-based specialist contract research organization (CRO). The Company is engaged in testing infectious and respiratory disease vaccines and …See details»
hVIVO Year in Review: Milestones, Growth and 2025 Ambitions
3 days ago In our recent interview with Mo Khan, CEO of hVIVO, we reflected on the company’s outstanding achievements in 2024 and gained insights into its ambitious roadmap for 2025. …See details»
hVIVO - Contacts, Employees, Board Members, Advisors & Alumni
Organization. hVIVO . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. Number of Board …See details»
hVIVO - Overview, News & Similar companies | ZoomInfo.com
Feb 1, 2023 hVIVO contact info: Phone number: +44 2071180727 Website: www.hvivo.com What does hVIVO do? Founded in 1989 and headquartered in London, UK, hVIVO is a …See details»
Environmental, Social & Governance - hVIVO
At hVIVO, we play an important role in improving global health by supporting the clinical development of medicinal products, especially infectious and respiratory disease products, …See details»
Corporate Governance Code | Investor Relations - hVIVO
Apr 23, 2024 The Company has successfully built a drug development consulting and clinical trial services capability in Europe. While this represents the operating capability of the …See details»
Latest Media Coverage - hVIVO
Oct 11, 2024 hVIVO – Foundations Laid For Strong Performance In The Months And Years Ahead, Institutions Building Up Stakes Ahead Of Interims . 18 Jul 2024. Pharmaceutical …See details»